Health Check: Telix shares rocket after bullish quarterly sales update
Telix's quarterly sales reflect first revenue from the company's recent purchase of a US nuclear medicine manufacturer
Island Pharma hopes to lift the kimono on its dengue fever trial next month
Race Oncology kicks off its cancer-busting, cardioprotective trial
Having gleaned all its revenue to date from its US-approved prostate cancer imaging agent Illucix, Telix Pharmaceuticals (ASX:TLX) is starting to reap the benefit of its acquisition of a US nuclear medicine manufacturer.
In September last year Telix paid US$230 million for RLS Radiopharmacies, which has 31 nuclear pharmacies dotted across Trumpland.
Telix has reported March quarter revenue of US$186 million, 62% higher year on year and 31% up on the December quarter.
This includes a robust US$33 million from RLS, which Telix formally acquired on January 27 this year.
'This strategic acquisition has significantly expanded our manufacturing footprint in the US, which we believe is an increasingly important consideration amid changing global trade dynamics,' says Telix chief Dr Chris Behrenbruch.
Ah, tariffs! We get it.
Illucix sales continue at a decent clip: US$151 million, up 35% year on year.
'Illuccix has continued its momentum, gaining market share and maintaining price stability in a competitive landscape,' Behrenbruch says.
Telix has affirmed guidance of full-year (calendar 2025) revenue of US$770-800 million, including eleven months of RLS sales.
The guidance is subject to change, given the US Food and Drug Administration (FDA) on March 21 approved Telix's second diagnostic, Gozellix (also for prostate cancer).
Telix hopes to launch Gozellix in the US in the current quarter, having appointed RLS and Cardinal Health as distribution partners.
Bursting development pipeline
Meanwhile, Telix expects FDA approval for its brain imaging candidate Pixclara by the end of this week – April 26.
As per the FDA's timetable, the agency should approval Telix's kidney cancer imaging candidate Zircaix by August 27.
Investors should expect an initial safety and dosing readout on phase III trial results for Telix's prostate cancer therapy (as opposed to diagnostic) in the current half.
Telix also hopes to submit an FDA investigational new drug application for its kidney cancer therapeutics, in view of a late-stage pivotal trial.
Adding to Telix's packed agenda, the company has earlier stage programs for a brain cancer therapy (phase II) and advanced, metastatic soft tissue sarcoma (phase I).
Telix shares this morning rocketed as much as 15%, but they are still well shy of their February 25 zenith of just over $31.
Investors may question just how much of the excitement is factored into Telix's $9.7 billion market capitalisation.
Island promises trial results next month
Island Pharmaceuticals (ASX:ILA) investors won't have to wait too much longer for results from the second stanza of the company's phase 2a/b dengue fever trial.
The 2a phase assessed the preventative qualities of Island's drug candidate ISLA-101 in four undiseased subjects, one of whom was administered a placebo.
The drug was deemed safe, with 'evidence of anti-dengue activity".
The 2b stage had enrolled ten patients who are administered a weakened form of the virus. Eight of them are administered ISLA-101, with two receiving a placebo.
Pharmacokinetic tests showed the drug reached the bloodstream in desired quantities.
Next month's results will outline the efficacy.
Carried by mosquitos, dengue fever has become a major health problem as it spreads at a rate that makes cane toads look slothful.
Race to start cancer trial
Race Oncology (ASX:RAC) expects to treat the first patient in its local phase 1 trial that tests its drug candidate RC-220 alongside a common chemotherapy agent.
RC-220 is a reformulated version of bisantrene, which was developed as a leukemia drug in France in the 1980s, but was never commercialised for reasons lost in the midst of time.
RC-220 shows promise not just for its cancer-busting properties, but its ability to protect the heart from the dire effects of chemotherapy.
The trial custodians are treating initial patients at the Southside Cancer Care Centre at Sydney's Miranda. Race has also gained ethics approval to open sites at the Gosford and Wyong hospitals.
Race's March quarterly report discloses cash of $17.12 million, with 70% of the $1.67 million quarterly burn devoted to R&D.
'This prudent cash management enables Race to fund all announced clinical and preclinical programs through calendar 2026," the company says.
Race costs the circa 53-patient RC-220 trial at $8.58 million.
An FDA decision to dye for
The latest decision by US health czar Robert F. Kennedy Junior and FDA commissioner Marty Makary could be one of their least controversial.
The FDA has banned petroleum-based synthetic dyes from food, as used sweets, soft drinks and other stuff that isn't good for you.
Depending on their colour, dyes are thought to be carcinogenic or cause behavioural problems in some children.
One of President Biden's last acts in power was to ban an especially controversial red dye from food and ingested drugs, after the additive was found to cause cancer in rats.
Technically, the dye no longer is 'generally recognised as safe'.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News.com.au
35 minutes ago
- News.com.au
DXN's Hawaii deal backs the rise of modular data centres
ASX-listed DXN lands Hawaii deal Modular data centre is becoming default option From Pilbara to defence, demand is booming An Aussie company just scored a job in Hawaii, and no, it's not a surfing gig. Last Monday DXN (ASX:DXN), a Sydney-based manufacturer of modular data centres, landed a $4.6 million contract with US satellite communications group, Globalstar. By the end of next year, DXN will ship three prefabricated data centres to Maui. These are high-performance, tailor-made data units designed to handle the unique demands of satellite comms in a remote, high-pressure environment. It's a big moment for DXN. The company beat out international contenders in a competitive bid and came out on top because it could do something not everyone can – build complex, custom-built data infrastructure fast and get it exactly right. The reason that matters is because the world is in a data arms race. And building traditional data centres the old-fashioned way – brick by brick – just isn't going to cut it anymore. This is where modular comes in. Box, ship, plug in Modular data centres are like prefab homes for the digital world. Instead of building from scratch on-site, everything – including the cooling, power, server racks, security systems – is constructed offsite inside a factory, then shipped as a complete unit to wherever it's needed. The result is a fully functional data centre that can be dropped into place and switched on in a fraction of the time it takes to build a traditional facility. Whether it's out in the Pilbara mining belt or at a satellite uplink in Maui, these things are designed to handle rough conditions. In the case of DXN's Hawaii deal, that means building three state-of-the-art modules that can support satellite communications. The fact that Globalstar, a US telco with a fleet of LEO (Low Earth Orbit) satellites, picked DXN says a lot about where this Aussie company is headed. But it also says something bigger about where the industry is going. Right now, demand for data is exploding. Think AI, cloud computing, self-driving cars, remote operations. All of that needs massive processing power, and it needs it close to where the data is being generated. That means no more waiting two years to build a shiny new data centre in a CBD. We're talking weeks, not months. Remote, not centralised. Flexible, not fixed. That's the problem modular data centres solve. They get built fast, cost less, and scale easily. If you need more computing power, just add another unit. They also make financial sense. Traditional data centres cost between $10 and $25 million per megawatt of IT capacity. Modular designs can cut that to around $5 million. That's a big saving, especially when you're trying to scale up quickly in ten different locations at once. Gaining fast traction The Australian Department of Defence recognised these advantages back in 2020 when it awarded a $20 million contract to Canberra-based company Datapod to provide portable, containerised data systems. These systems could be rapidly deployed by sea, air or road, ensuring the department had the agility to respond to evolving threats. In regional Australia, where mining and energy drive the economy, modular centres are quickly becoming the default option. In 2024, the remote town of Newman in WA's Pilbara region received a modular unit, called NE1 Newman, from NEXTDC to support edge computing for nearby mine sites. There's no way a traditional build would've made it there in time or on budget. Big tech firms like Google, Microsoft and Tencent are also investing heavily in modular builds. And private investors, too, are taking notice. Data centres are now seen as some of the best-performing assets in the property market, outpacing even industrial warehouses. ASX stocks in this space DXN can lay claim to being the only pure-play modular data centre stock on the ASX. But other players are also in the game, just playing different versions of it. NextDC (ASX:NXT) runs the big, purpose-built data centres in major cities. Then there's Macquarie Telecom Group (ASX:MAQ), which offers enterprise-grade data centres. Global Data Centre Group (ASX:GDC) is more of an investor; it holds a portfolio of data centre assets around the world. In the big end of town, Megaport (ASX:MP1) is a heavyweight in cloud connectivity, offering networking software that links over 950 data centres worldwide. Dicker Data (ASX:DDR), on the other hand, is Australia's leading IT distributor, supplying cloud solutions from top-tier vendors to over 8200 reseller partners across ANZ. In the REITs space, DigiCo Infrastructure REIT (ASX:DGT) owns and manages digital infrastructure real estate, including towers, fibre, and data centre buildings. Companies like Adisyn (ASX:AI1), meanwhile, are playing in an adjacent but related space – developing graphene-powered tech to help cool the next generation of data-hungry chips. At Stockhead we tell it like it is. While Adisyn is a Stockhead advertiser, it did not sponsor this article.
The Advertiser
an hour ago
- The Advertiser
Path to going public on markets sped up for companies
Companies wanting to list on the stock market will be given a fast track by the corporate watchdog to go public. Changes put forward by the Australian Securities and Investment Commission will mean companies could reduce the time needed in order to take a company public by one week. The watchdog will now work with companies two weeks before documents laying out details about an initial public offering are made available to the public. ASIC says it will lessen the risk of potential investors being scared off by volatile markets. The changes are being rolled out as part of a two-year trial to reverse a decline in companies going public on the Australian market. The number of companies going public hit a 20-year low in 2024, with just 29 initial public offerings on the ASX. That compares with the 240 new listings on the ASX in 2021. Commission chair Joe Longo said the changes would provide greater confidence in the stock market. "Creating a more streamlined IPO process underscores our commitment to ensuring our public markets remain attractive to companies and investors," he said. "Greater deal certainty for companies should help deliver more IPOs, which means more investment opportunities so companies can expand, increase jobs and ultimately economic growth." The changes are being announced ahead of a symposium being held by the commission on Tuesday in Sydney about the future of Australia's markets. A discussion paper put out by the commission in February said the number of publicly listed companies had been declining in many developed markets over decades. "The Australian market is concentrated, with most companies in the financials and mining sectors, and less represented in sectors that will drive growth in our increasingly digital future," the paper said. "Many companies are choosing to stay private where new funding and sell downs are now more accessible, while others are choosing to list in the United States." Mr Longo said further reforms were being considered to boost the number of new listings. "While we do not see regulatory settings as the silver bullet, we have received lots of ideas and are considering further regulatory adjustments to support a strong and well-functioning market," he said. Companies wanting to list on the stock market will be given a fast track by the corporate watchdog to go public. Changes put forward by the Australian Securities and Investment Commission will mean companies could reduce the time needed in order to take a company public by one week. The watchdog will now work with companies two weeks before documents laying out details about an initial public offering are made available to the public. ASIC says it will lessen the risk of potential investors being scared off by volatile markets. The changes are being rolled out as part of a two-year trial to reverse a decline in companies going public on the Australian market. The number of companies going public hit a 20-year low in 2024, with just 29 initial public offerings on the ASX. That compares with the 240 new listings on the ASX in 2021. Commission chair Joe Longo said the changes would provide greater confidence in the stock market. "Creating a more streamlined IPO process underscores our commitment to ensuring our public markets remain attractive to companies and investors," he said. "Greater deal certainty for companies should help deliver more IPOs, which means more investment opportunities so companies can expand, increase jobs and ultimately economic growth." The changes are being announced ahead of a symposium being held by the commission on Tuesday in Sydney about the future of Australia's markets. A discussion paper put out by the commission in February said the number of publicly listed companies had been declining in many developed markets over decades. "The Australian market is concentrated, with most companies in the financials and mining sectors, and less represented in sectors that will drive growth in our increasingly digital future," the paper said. "Many companies are choosing to stay private where new funding and sell downs are now more accessible, while others are choosing to list in the United States." Mr Longo said further reforms were being considered to boost the number of new listings. "While we do not see regulatory settings as the silver bullet, we have received lots of ideas and are considering further regulatory adjustments to support a strong and well-functioning market," he said. Companies wanting to list on the stock market will be given a fast track by the corporate watchdog to go public. Changes put forward by the Australian Securities and Investment Commission will mean companies could reduce the time needed in order to take a company public by one week. The watchdog will now work with companies two weeks before documents laying out details about an initial public offering are made available to the public. ASIC says it will lessen the risk of potential investors being scared off by volatile markets. The changes are being rolled out as part of a two-year trial to reverse a decline in companies going public on the Australian market. The number of companies going public hit a 20-year low in 2024, with just 29 initial public offerings on the ASX. That compares with the 240 new listings on the ASX in 2021. Commission chair Joe Longo said the changes would provide greater confidence in the stock market. "Creating a more streamlined IPO process underscores our commitment to ensuring our public markets remain attractive to companies and investors," he said. "Greater deal certainty for companies should help deliver more IPOs, which means more investment opportunities so companies can expand, increase jobs and ultimately economic growth." The changes are being announced ahead of a symposium being held by the commission on Tuesday in Sydney about the future of Australia's markets. A discussion paper put out by the commission in February said the number of publicly listed companies had been declining in many developed markets over decades. "The Australian market is concentrated, with most companies in the financials and mining sectors, and less represented in sectors that will drive growth in our increasingly digital future," the paper said. "Many companies are choosing to stay private where new funding and sell downs are now more accessible, while others are choosing to list in the United States." Mr Longo said further reforms were being considered to boost the number of new listings. "While we do not see regulatory settings as the silver bullet, we have received lots of ideas and are considering further regulatory adjustments to support a strong and well-functioning market," he said. Companies wanting to list on the stock market will be given a fast track by the corporate watchdog to go public. Changes put forward by the Australian Securities and Investment Commission will mean companies could reduce the time needed in order to take a company public by one week. The watchdog will now work with companies two weeks before documents laying out details about an initial public offering are made available to the public. ASIC says it will lessen the risk of potential investors being scared off by volatile markets. The changes are being rolled out as part of a two-year trial to reverse a decline in companies going public on the Australian market. The number of companies going public hit a 20-year low in 2024, with just 29 initial public offerings on the ASX. That compares with the 240 new listings on the ASX in 2021. Commission chair Joe Longo said the changes would provide greater confidence in the stock market. "Creating a more streamlined IPO process underscores our commitment to ensuring our public markets remain attractive to companies and investors," he said. "Greater deal certainty for companies should help deliver more IPOs, which means more investment opportunities so companies can expand, increase jobs and ultimately economic growth." The changes are being announced ahead of a symposium being held by the commission on Tuesday in Sydney about the future of Australia's markets. A discussion paper put out by the commission in February said the number of publicly listed companies had been declining in many developed markets over decades. "The Australian market is concentrated, with most companies in the financials and mining sectors, and less represented in sectors that will drive growth in our increasingly digital future," the paper said. "Many companies are choosing to stay private where new funding and sell downs are now more accessible, while others are choosing to list in the United States." Mr Longo said further reforms were being considered to boost the number of new listings. "While we do not see regulatory settings as the silver bullet, we have received lots of ideas and are considering further regulatory adjustments to support a strong and well-functioning market," he said.
The Age
2 hours ago
- The Age
ASX set to rise, Wall Street boosted by US-China talks; $A stronger
US stocks are drifting closer to their records as the world's two largest economies begin talks on trade that could help avoid a recession. The S&P 500 was 0.3 per cent higher in late trading. The Dow Jones was up 93 points, or 0.2 per cent, with an hour remaining in trading, and the Nasdaq composite was 0.5 per cent higher. The Australian sharemarket is set to advance, with futures at 5am AEST pointing to a gain of 16 points, or 0.2 per cent, at the open. The ASX was closed on Monday for the King's birthday public holiday. The Australian dollar strengthened. It was 0.3 per cent higher at 65.25 US cents at 5.13am AEST. Officials from the United States and China are meeting in London to talk about a range of different disputes that are separating them. The hope is that they can eventually reach a deal that will lower each's punishing level of tariffs against the other, which are currently on pause, so that the flow of everything from tiny tech gadgets to enormous machinery can continue. Hopes that President Donald Trump will lower his tariffs after reaching such trade deals with countries around the world have been among the main reasons the S&P 500 has rallied so furiously since dropping roughly 20 per cent from its record two months ago. It's back within 2 per cent of its all-time high, which was set in February, and it's higher than it was before Trump shocked financial markets in April with his wide-ranging tariff announcement on what he called 'Liberation Day.' This may be the shortest sell-off following a shock of heightened volatility on record, according to Parag Thatte, Binky Chadha and other strategists at Deutsche Bank. Typically, stocks take around two months to bottom following a spike in volatility and then another four to five months to recover their losses. This time around, stocks have basically made a round trip in less than two months. But nothing is assured, of course, and that helped keep trading relatively quiet on Wall Street Monday. Loading Some of the market's biggest moves came from the announcement of big buyout deals. Qualcomm rallied 4.4 per cent after saying it agreed to buy Alphawave Semi in a deal valued at $2.4 billion. IonQ, meanwhile, rose 1.6 per cent after the quantum computing and networking company said it agreed to purchase Oxford Ionics for nearly $1.08 billion.
